What sector does Kaken Pharmaceutical Co Ltd (4521) operate in?
Kaken Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Kaken Pharmaceutical Co Ltd (4521) current stock price?
As of the latest data, Kaken Pharmaceutical Co Ltd stock price is ¥3,787, with a previous close of ¥3,791. Kaken Pharmaceutical Co Ltd lost -¥4 in the last trading session, representing a -0.11% loss.
What is Kaken Pharmaceutical Co Ltd (4521) current market capitalization?
Kaken Pharmaceutical Co Ltd market cap is approximately 143.39 billion.
What is Kaken Pharmaceutical Co Ltd (4521) Earnings Per Share (EPS)?
The trailing EPS is ¥365.
What is Kaken Pharmaceutical Co Ltd (4521) Price-to-Earnings (P/E) ratio?
Kaken Pharmaceutical Co Ltd current P/E ratio is 10.36.
What is Kaken Pharmaceutical Co Ltd (4521) EBITDA?
Kaken Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -4.73 billion.
Does Kaken Pharmaceutical Co Ltd (4521) pay dividends?
Yes. Kaken Pharmaceutical Co Ltd pays semiannual dividends with an annualized yield of 3.96% and an estimated annual payout of ¥150 per share.
When is the next ex-dividend date for Kaken Pharmaceutical Co Ltd (4521)?
The next ex-dividend date is scheduled for September 28, 2025.
When is Kaken Pharmaceutical Co Ltd (4521) next earnings report?
Kaken Pharmaceutical Co Ltd is expected to release its next earnings report on June 30, 2025.
What is Kaken Pharmaceutical Co Ltd (4521) beta (volatility) score?
Kaken Pharmaceutical Co Ltd has a beta of 0.031, indicating lower volatility than the overall market.